PharmaVoice 100

  • A person holds a magnet pointed at multi-colored wooden figures of people sitting on dark wood-grain table.
    Image attribution tooltip
    iStock via Getty Images

    Making moves: Agios, BeiGene, Biocom California and more announce new key hires

    The latest executive personnel changes from around the industry.

    By • July 18, 2022
  • Kerrie Brady head shot
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: OcuTerra Therapeutics' Kerrie Brady

    The serial entrepreneur and now head of OcuTerra explains why taking risks in pharma pays off.

    By • June 1, 2022
  • Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma
    Image attribution tooltip

    Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma and one of this year's HBA Luminary honorees. 

    Opinion

    Why 'soft' skills matter in the new era of leadership

    Standout leaders honored by the Healthcare Businesswomen's Association discuss the rising value of the interpersonal approach.

    By • May 12, 2022
  • This week's Woman of the Week Michelle Marlborough of AiCure shares her journey and leadership lessons.
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: AiCure's Michelle Marlborough

    As chief product officer at AiCure, Michelle Marlborough is focused on solving tough patient challenges through technology.

    By • May 11, 2022
  • Image attribution tooltip

    Sangamo Therapeutics

    Q&A

    Sangamo has its finger on the next evolution of gene editing

    Sangamo Therapeutics' CEO Sandy Macrae is bullish on his company’s ability to transform the genomic medicine arena.

    By • March 31, 2022
  • This week's Woman of the Week Sabrina Martucci Johnson shares how she is looking to transform women's health
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Daré Bioscience's Sabrina Martucci Johnson

    The CEO is setting a path to transform women’s health at an opportune time.

    By • March 30, 2022
  • This week's Woman of the Week Quita Highsmith, shares how she is transforming healthcare by focusing on DE&I
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Genentech's Quita Highsmith

    Quita Highsmith is changing how Genentech approaches diversity and inclusion across the board — from drug development to career advancement.

    By • March 9, 2022
  • Image attribution tooltip

    Permission granted by Ramona Sequeira.

    Q&A

    Ramona Sequeira breaks PhRMA's glass ceiling

    A few weeks ago, PhRMA, the industry’s largest trade group, announced that Sequeira has officially become chair of the organization’s board of directors. She is the first woman — and first woman of color — to take on the job.

    By • March 7, 2022
  • This week's Woman of the Week Dr. Trish Hurter, shares her key leadership strategies for success.
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Lyndra Therapeutics' CEO Dr. Trish Hurter

    With Lyndra's ultra-long-acting therapies, Hurter and the company are aiming to reinvent medicines.

    By • March 2, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice

    The 2022 PharmaVoice 100 — new look, same drive for excellence

    Some of the industry’s biggest names have been on our list of honorees. Now it’s time to find this year’s inspiring leaders.  

    By • Feb. 28, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Candel's CEO looks to help ignite a new era of cancer treatments

    Candel Therapeutics is advancing a next-gen approach in oncology: using viruses to kill cancer cells at the site of injection.

    By • Feb. 28, 2022
  • headshot
    Image attribution tooltip
    Permission granted by Guadalupe Hayes-Mota
    Profile

    Guadalupe Hayes-Mota's 'recipe' for tackling pharma's supply chain issues

    A quest to expand access to medical treatment globally led to a new career path when Guadalupe Hayes-Mota left his biotech leadership roles to start his own company. 

    By Robin Robinson • Feb. 25, 2022
  • This week's Woman of the Week Adele Gulfo of Sumitovant shares her career journey to the C-suite
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Sumitovant's Chief Business Development and Commercial Officer Adele Gulfo

    Adele Gulfo, chief business development and commercial officer at Sumitovant Biopharma, is leaning into her decades of experience to bring a future-focused approach to drug development.

    By • Feb. 23, 2022
  • headshot
    Image attribution tooltip
    Courtesy of Saniona
    Q&A

    Saniona's CEO on why it takes a village to develop treatments for a rare disease

    Saniona built its village by first hiring a head of patient advocacy.

    By Kim Ribbink • Feb. 8, 2022
  • headshot
    Image attribution tooltip
    Courtesy of Ferring Pharma

    Ferring Pharmaceuticals president discusses the need for more funding in women's health research

    Read why women's healthcare funding is such a challenge.

    By Robin Robinson • Feb. 4, 2022
  • computer keyboard test tube
    Image attribution tooltip
    Retrieved from Google image.
    Opinion

    Industry executives predict the next 'blue oceans' in pharma

    Where life science leaders see breakthroughs happening in the industry.

    By • Feb. 4, 2022
  • headshot
    Image attribution tooltip
    Permission granted by Mary Harmon
    Q&A

    PTC's vice president of patient relations outlines the importance of patient input in rare disease R&D

    You can't know what matters to rare disease patients unless you ask them.

    By Kim Ribbink • Feb. 3, 2022
  • headshot
    Image attribution tooltip
    Permission granted by Peter Anastasiou
    Q&A

    New Capsida Biotherapeutics CEO Peter Anastasiou aims to bring AAV therapy to reality

    Read what Capsida CEO Peter Anastasiou has planned for his new role. 

    By • Feb. 3, 2022
  • This week's Woman of the Week Andrea McGonigle of Google Cloud, shares lessons in leadership, technology transformation
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Google Cloud's Andrea McGonigle

    Andrea McGonigle, Google Cloud’s general manager, healthcare and life sciences partnerships and strategic initiatives, is intent on bringing technology and innovation together to solve some of the biggest challenges in healthcare.

    By • Feb. 2, 2022
  • Three people are having an in-office meeting
    Image attribution tooltip
    Pekic via Getty Images
    Opinion

    Talent acquisition stays top of mind for pharma execs

    From creating flexible work environments to looking outside the industry for new talent, pharma execs are shifting strategies to keep their teams afloat.

    By • Feb. 1, 2022
  • Image attribution tooltip
    Retrieved from Rare Disease.org.
    Q&A

    For the CEO of Travere, running a rare disease company is personal

    To kick off Rare Disease month, we interview the CEO of Travere Therapeutics

    By Kim Ribbink • Feb. 1, 2022
  • Image attribution tooltip
    The image by Pixabay is licensed under CC BY 1.0
    Q&A

    Foghorn's CEO on why collaborations are key to unlocking precision medicine

    With a major development deal under his belt, Adrian Gottschalk is helping the company advance its innovative platform.

    By Robin Robinson • Jan. 28, 2022
  • headshot
    Image attribution tooltip
    Retrieved from Google image.
    Profile

    Evofem CEO Saundra Pelletier aims to level the playing field between men's and women's health

    Evofem CEO and PharmaVoice100, Saundra Pelletier, discusses funding challenges for women's health.

    By Alexandra Pecci • Jan. 23, 2022
  • women's health orange and pink
    Image attribution tooltip
    Permission granted by Copyright: <a href='https://www.123rf.com/profile_ileezhun'>ileezhun</a>

    Biote CEO breaks down barriers in women's health

    Women’s health is coming into sharper focus in 2022, but getting funding is still difficult.

    By Robin Robinson • Jan. 11, 2022
  • photo of Ovid tweet
    Image attribution tooltip
    [photo]. Retrieved from Ovid Therapeutics.
    Q&A

    Ovid's CEO shares his vision for rare disease developments

    Jeremy Levin, chairman and CEO of Ovid Therapeutics discusses the keys to success in rare disease innovation.

    By Kim Ribbink • Jan. 10, 2022